<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-ijms-21-09257">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chouiter</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Boulebd</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Pereira</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Valent√£o</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Andrade</surname>
    <given-names>P.B.</given-names>
   </name>
   <name>
    <surname>Belfaitah</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Silva</surname>
    <given-names>A.M.S.</given-names>
   </name>
  </person-group>
  <article-title>New chalcone-type compounds and 2-pyrazoline derivatives: Synthesis and caspase-dependent anticancer activity</article-title>
  <source>Future Med. Chem.</source>
  <year>2020</year>
  <volume>12</volume>
  <fpage>493</fpage>
  <lpage>509</lpage>
  <pub-id pub-id-type="doi">10.4155/fmc-2019-0342</pub-id>
  <pub-id pub-id-type="pmid">32100558</pub-id>
 </element-citation>
</ref>
